Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px
Organisation › Details

H. Lundbeck A/S

H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international pharmaceutical company highly committed to improving the quality of life for people suffering from brain disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company's products are targeted at disorders such as depression and anxiety, schizophrenia, insomnia, epilepsy and Huntington's, Alzheimer's and Parkinson's diseases. Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today Lundbeck employs approximately 5,900 people worldwide. Lundbeck is one of the world's leading pharmaceutical companies working with brain disorders. In 2010, the company's revenue was DKK 14.8 billion (approximately EUR 2.0 billion or USD 2.6 billion). *

 

Period Start 1990-01-01 existent
  Group Lundbeck (Group)
Products Industry pharmaceutical
  Industry 2 psychopharmaceutical
Persons Person Schultz, Kåre (Teva 201709– CEO announced before Lundbeck 201505– CEO before Novo Nordisk COO)
  Person 2 Götzsche, Anders (Lundbeck 201309 CFO)
     
Region Region København (Copenhagen)
  Country Denmark
  Street 9 Ottiliavej
  City 2500 Valby
  Tel +45-3630-1311
    Address record changed: 2018-07-24
     
Basic data Employees G: 5,001 to 10,000 (2015-12-31)
  Currency DKK
  Annual sales 6,276,000,000 (revenue, consolidated (2017) 2017-12-31)
  Profit 1,208,000,000 (2017-12-31)
  Cash 1,680,000,000 (2017-12-31)
     
    * Document for �About Section�: H. Lundbeck A/S. (11/22/11). "Press Release: NDA for Aripiprazole Depot Formulation for Maintenance Treatment of Adult Patients with Schizophrenia Accepted by the FDA".
     
   
Record changed: 2018-10-30

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Lundbeck (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px




» top